Skip Navigation

A Phase 1 Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 Daunorubicin and Cytarabine Liposome for Injection Treatment in Adult Patients with Hematologic Malignancies

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03555955

Study #:
STUDY00142684

Start Date:
Feb 13, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03555955

View Complete Trial Details & Eligibility at ClinicalTrials.gov